PubRank

T Palomo

Author PubWeight™ 31.95‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Impulsivity and sustained attention in pathological gamblers: influence of childhood ADHD history. J Gambl Stud 2006 1.12
2 Clinical predictors of response to naltrexone in alcoholic patients: who benefits most from treatment with naltrexone? Alcohol Alcohol 2005 1.03
3 SUNCT syndrome: repetitive and overlapping attacks. Headache 1994 1.03
4 Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats. Eur J Pharmacol 1999 0.99
5 Effects of topiramate in the treatment of alcohol dependence. Pharmacopsychiatry 2004 0.99
6 Performance in the Wisconsin Card Sorting Test and the C957T polymorphism of the DRD2 gene in healthy volunteers. Neuropsychobiology 2007 0.97
7 Extinction of cocaine self-administration produces a differential time-related regulation of proenkephalin gene expression in rat brain. Neuropsychopharmacology 2001 0.92
8 Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder. Eur Psychiatry 2007 0.92
9 Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment. Pharmacol Biochem Behav 1994 0.91
10 The A1 allele of the DRD2 gene (TaqI A polymorphisms) is associated with antisocial personality in a sample of alcohol-dependent patients. Eur Psychiatry 2003 0.90
11 The TaqIA polymorphism linked to the DRD2 gene is related to lower attention and less inhibitory control in alcoholic patients. Eur Psychiatry 2005 0.88
12 "Hemicrania episodica"--a new type of headache or a pre-chronic stage of hemicrania continua? Headache 1990 0.87
13 Association between cannabinoid receptor gene (CNR1) and childhood attention deficit/hyperactivity disorder in Spanish male alcoholic patients. Mol Psychiatry 2003 0.87
14 The MATRICS consensus cognitive battery (MCCB): co-norming and standardization in Spain. Schizophr Res 2011 0.86
15 DRD2 and ANKK1 genotype in alcohol-dependent patients with psychopathic traits: association and interaction study. Br J Psychiatry 2008 0.86
16 Treatment of tardive dyskinesia with aripiprazole. Neurotox Res 2009 0.85
17 Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment. Alcohol Alcohol 2001 0.85
18 The ANKK1 protein associated with addictions has nuclear and cytoplasmic localization and shows a differential response of Ala239Thr to apomorphine. Neurotox Res 2010 0.85
19 High frequency of childhood ADHD history in women with fibromyalgia. Eur Psychiatry 2010 0.81
20 C957T DRD2 polymorphism is associated with schizophrenia in Spanish patients. Acta Psychiatr Scand 2006 0.81
21 The D2 dopamine receptor gene variant C957T affects human fear conditioning and aversive priming. Genes Brain Behav 2009 0.81
22 [Validation in the adult Spanish population of the Wender Utah Rating Scale for the retrospective evaluation in adults of attention deficit/hyperactivity disorder in childhood]. Rev Neurol 2001 0.80
23 Differential clinical, structural and P300 parameters in schizophrenia patients resistant to conventional neuroleptics. Prog Neuropsychopharmacol Biol Psychiatry 2007 0.80
24 Marked hypofrontality in clozapine-responsive patients. Pharmacopsychiatry 2007 0.80
25 Pulmonary perivascular and interstitial inflammation in MRL/MpJ-lpr/lpr mice. III. Modulation by cyclophosphamide and sex hormones in 4- and 6-month-old animals. Clin Immunol Immunopathol 1991 0.80
26 Cerebral metabolism and risperidone treatment in schizophrenia. Schizophr Res 2003 0.79
27 Gray matter deficits in bipolar disorder are associated with genetic variability at interleukin-1 beta gene (2q13). Genes Brain Behav 2008 0.78
28 P300 amplitude as a possible correlate of frontal degeneration in schizophrenia. Schizophr Res 2001 0.78
29 Effects of co-administration of anticonvulsant and putative anticonvulsive agents and sub/suprathreshold doses of L-dopa upon motor behaviour of MPTP-treated mice. J Neural Transm (Vienna) 1999 0.77
30 Psychopathology and Wisconsin Card Sorting Test performance in male schizophrenic patients: influence of dual diagnosis. Psychopathology 2007 0.77
31 Positive and negative schizophrenic symptoms and the role of dopamine. Br J Psychiatry 1981 0.77
32 Tolerance to a suprathreshold dose of L-Dopa in MPTP mice: effects of glutamate antagonists. J Neural Transm (Vienna) 1999 0.76
33 Changes in cortical volume with olanzapine in chronic schizophrenia. Pharmacopsychiatry 2007 0.76
34 Incidence and lifetime risk of dementia and Alzheimer's disease in a Southern European population. Acta Psychiatr Scand 2011 0.76
35 Hemicrania continua. The first Spanish case: a case report. Cephalalgia 1990 0.75
36 A model to test the relative potencies of phosphodiesterase inhibitors in brain (in vivo) [proceedings]. Br J Pharmacol 1977 0.75
37 IDRD2 TaqIA polymorphism is associated with urinary homovanillic acid levels in a sample of Spanish male alcoholic patients. Neurotox Res 2004 0.75
38 Drug induced supersensitivity and choline acetyltransferase (ChA) activity in the rat striatum [proceedings]. Br J Pharmacol 1978 0.75
39 Restorative effects of glutamate antagonists in experimental parkinsonism. Amino Acids 2002 0.75
40 [Executive dysfunctions in adults with attention deficit hyperactivity disorder]. Rev Neurol 2006 0.75
41 Differential relationships between set-shifting abilities and dimensions of insight in schizophrenia. Psychopathology 2013 0.75
42 [Endocannabinoid system and CNR1 gene polymorphisms in schizophrenia and addictive disorders]. Actas Esp Psiquiatr 2007 0.75
43 Effects of MAO inhibitors upon MPTP mice chronically treated with suprathreshold doses of L-dopa. Behav Pharmacol 2000 0.75
44 Neuroprotective and neurorestorative strategies for neuronal injury. Neurotox Res 2000 0.75
45 Neurotoxicity and substance abuse: further fuel for regulatory dilemma. Neurotox Res 2001 0.75
46 Neonatal nicotine administration influences ethanol-induced behaviors. Alcohol 2000 0.75
47 [Oxcarbazepine in the prevention of epileptic syndromes in alcohol detoxification]. Rev Neurol 2005 0.75
48 [Depressive disorder and craniopharyngioma]. Rev Neurol 2003 0.75
49 [Efficacy of naltrexone in the treatment of alcohol dependence disorder in women]. Actas Esp Psiquiatr 2005 0.75